Multiple sclerosis (MS) is a neurodegenerative disease characterised by chronic infla...
A recent exploratory trial looking at the effect of the drug MIS416 on patients has f...
More than 400 participants and support crew descended on the picturesque Central ...
The Multiple Sclerosis team has been working with a New Zealand biomedical company...
Professor Anne La Flamme and her Multiple Sclerosis (MS) research group recently publ...
With an impressive 238 participants taking part this year, it’s been another successf...
Over the last 8 years, The Great New Zealand Trek has donated $245,000 to help find a...
A Phase Ib/IIa suitability and acceptability trial of two antipsychotic medicines, cl...
The journey to deliver a new (and first-ever) treatment for secondary progressive MS ...
On Thursday night, 14 August 2014, Dr Anne La Flamme's latest Multiple Sclerosis rese...